HLA-DRA

HLA-DRA
Dostupne strukture PDB Pretraga ortologa: PDBe RCSB Spisak PDB ID kodova 1A6A, 1AQD, 1BX2, 1D5M, 1D5X, 1D5Z, 1D6E, 1DLH, 1FV1, 1FYT, 1H15, 1HXY, 1J8H, 1JWM, 1JWS, 1JWU, 1KG0, 1KLG, 1KLU, 1LO5, 1PYW, 1R5I, 1SEB, 1SJE, 1SJH, 1T5W, 1T5X, 1YMM, 1ZGL, 2FSE, 2G9H, 2IAM, 2IAN, 2ICW, 2IPK, 2OJE, 2Q6W, 2WBJ, 2XN9, 3C5J, 3L6F, 3O6F, 3PDO, 3PGC, 3PGD, 3QXA, 3QXD, 3S4S, 3S5L, 3T0E, 4AEN, 4AH2, 4E41, 4FQX, 4GBX, 4H1L, 4C56, 4H25, 4H26, 4I5B, 4IS6, 4MCY, 4MCZ, 4MD0, 4MD4, 4MD5, 4MDI, 4MDJ, 4OV5, 4Y19, 4Y1A, 4X5X, 4X5W
Identifikatori
Aliasi	HLA-DRA
Vanjski ID-jevi	OMIM: 142860 MGI: 95900 HomoloGene: 7751 GeneCards: HLA-DRA
Lokacija gena (čovjek) Hrom. Hromosom 6 (čovjek) Bend 6p21.32 Početak 32,439,878 bp Kraj 32,445,046 bp
Obrazac RNK ekspresije Više referentnih podataka o ekspresiji
Ontologija gena Molekularna funkcija • peptide antigen binding • MHC class II receptor activity • MHC class II protein complex binding • GO:0001948, GO:0016582 vezivanje za proteine Ćelijska komponenta • integral component of membrane • endocytic vesicle membrane • clathrin-coated endocytic vesicle membrane • endozom • Golđijev aparat • trans-Golgi network membrane • endoplasmic reticulum membrane • membrana • late endosome membrane • Golđijeva membrana • ćelijska membrana • transport vesicle membrane • integral component of plasma membrane • cell surface • lysosomal membrane • Endoplazmatski retikulum • ER to Golgi transport vesicle membrane • Lizozom • integral component of lumenal side of endoplasmic reticulum membrane • endosome membrane • Egzosom • MHC class II protein complex Biološki proces • antigen processing and presentation • antigen processing and presentation of exogenous peptide antigen via MHC class II • kognitivna funkcija • interferon-gamma-mediated signaling pathway • immune system process • T cell costimulation • antigen processing and presentation of peptide or polysaccharide antigen via MHC class II • GO:0046730, GO:0046737, GO:0046738, GO:0046736 Imuni odgovor • peptide antigen assembly with MHC class II protein complex • GO:0022415 viral process • T cell receptor signaling pathway • adaptive immune response Izvori:Amigo / QuickGO
Ortolozi
Vrste	Čovjek	Miš
Entrez	3122	100504404
Ensembl	ENSG00000206308 ENSG00000228987 ENSG00000230726 ENSG00000204287 ENSG00000227993 ENSG00000226260 ENSG00000234794 ENSG00000277263	ENSMUSG00000036322
UniProt	P01903	P04224 P01904
RefSeq (mRNK)	NM_019111	NM_010381
RefSeq (bjelančevina)	NP_061984	NP_034511
Lokacija (UCSC)	Chr 6: 32.44 – 32.45 Mb	n/a
PubMed pretraga
Wikipodaci
Pogledaj/uredi – čovjek Pogledaj/uredi – miš

DR alfa-lanac HLA klase II antigena histokompatibilnosti jest protein koji je kod ljudi kodiran genom HLA-DRA. HLA-DRA kodira alfa podjedinicu HLA-DR. Za razliku od alfa lanaca drugih ljudskih molekula kompleksne klase II MHC, alfa podjedinica je praktično nepromjenjiva. Međutim, može se upariti sa, u bilo koje osobe, beta-lancem iz tri različita DR beta lokusa, DRB1 i dva bilo koja od DRB3, aleli DRB4 ili DRB5. Stoga postoji potencijal da bilo koja osoba može formirati četiri različite HLA-DR izoforme (po dva alela DRB1 i DRB3, DRB4 ili DRB5).

Aminokiselinska sekvenca

Dužina polipeptidnog lanca je 254 aminokiseline, а molekulska težina Da. 28 607

• C: Cistein
• D: Asparaginska kiselina
• E: Glutaminska kiselina
• F: Fenilalanin
• G: Glicin
• H: Histidin
• I: Izoleucin
• K: Lizin
• L: Leucin
• M: Metionin
• N: Asparagin
• P: Prolin
• Q: Glutamin
• R: Arginin
• S: Serin
• T: Treonin
• V: Valin
• W: Triptofan
• Y: Tirozin

10		20		30		40		50
MAISGVPVLG		FFIIAVLMSA		QESWAIKEEH		VIIQAEFYLN		PDQSGEFMFD
FDGDEIFHVD		MAKKETVWRL		EEFGRFASFE		AQGALANIAV		DKANLEIMTK
RSNYTPITNV		PPEVTVLTNS		PVELREPNVL		ICFIDKFTPP		VVNVTWLRNG
KPVTTGVSET		VFLPREDHLF		RKFHYLPFLP		STEDVYDCRV		EHWGLDEPLL
KHWEFDAPSP		LPETTENVVC		ALGLTVGLVG		IIIGTIFIIK		GVRKSNAAER
RGPL

Genska struktura i polimorfizmi

Alfa-lanac je težak približno 33-35 kDa, a njegov gen sadrži pet egzona. Egzon 1 kodira vodeći peptid, egzoni 2 i 3 kodiraju dva vanćelijska domena, a egzon 4 kodira transmembranski domen i citoplazmatski rep. DRA nema polimorfizme u dijelu koji se veže za peptide i djeluje kao jedini alfa-lanac za DRB1, DRB3, DRB4 i DRB5.

Aleli

U ljudskoj populaciji postoje dva različita lanca HLA-DRA, kodirana s tri različita alela DRA:

DRA*01: 01 DRA*01: 02: 01 DRA*01: 02: 02

Funkcija

Polipeptidna podjedinica kodirana ovim genom pripada alfa-lancu HLA klasi II paraloga. Protein klase II je heterodimer koji se sastoji od alfa (DRα) i beta-lanca (DRβ), oba usidrena u membrani. Ima centralnu ulogu u imunskom sistemu predstavljajući peptide izvedene iz vanćelijskih proteina. Molekule klase II su eksprimirane u ćelijama koje prezentiraju antigene (APC: B limfociti, dendritske ćelije, makrofagi).

Također pogledajte

• HLA-DR
• HLA

Dopunska literatura

• Bénichou S, Benmerah A (2003). "[The HIV nef and the Kaposi-sarcoma-associated virus K3/K5 proteins: "parasites"of the endocytosis pathway]". Med Sci (Paris). 19 (1): 100–6. doi:10.1051/medsci/2003191100. PMID 12836198.
• Tolstrup M, Ostergaard L, Laursen AL, et al. (2004). "HIV/SIV escape from immune surveillance: focus on Nef". Curr. HIV Res. 2 (2): 141–51. doi:10.2174/1570162043484924. PMID 15078178.
• Anderson JL, Hope TJ (2005). "HIV accessory proteins and surviving the host cell". Current HIV/AIDS Reports. 1 (1): 47–53. doi:10.1007/s11904-004-0007-x. PMID 16091223. S2CID 34731265.
• Li L, Li HS, Pauza CD, et al. (2006). "Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions". Cell Res. 15 (11–12): 923–34. doi:10.1038/sj.cr.7290370. PMID 16354571.
• Stove V, Verhasselt B (2006). "Modelling thymic HIV-1 Nef effects". Curr. HIV Res. 4 (1): 57–64. doi:10.2174/157016206775197583. PMID 16454711.
• Matsushima GK, Itoh-Lindstrom Y, Ting JP (1992). "Activation of the HLA-DRA gene in primary human T lymphocytes: novel usage of TATA and the X and Y promoter elements". Mol. Cell. Biol. 12 (12): 5610–9. doi:10.1128/MCB.12.12.5610. PMC 360500. PMID 1448091.
• Schaiff WT, Hruska KA, McCourt DW, et al. (1992). "HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells". J. Exp. Med. 176 (3): 657–66. doi:10.1084/jem.176.3.657. PMC 2119345. PMID 1512535.
• Piatier-Tonneau D, Gastinel LN, Amblard F, et al. (1991). "Interaction of CD4 with HLA class II antigens and HIV gp120". Immunogenetics. 34 (2): 121–8. doi:10.1007/BF00211424. PMID 1869305. S2CID 10116507.
• Nong Y, Kandil O, Tobin EH, et al. (1991). "The HIV core protein p24 inhibits interferon-gamma-induced increase of HLA-DR and cytochrome b heavy chain mRNA levels in the human monocyte-like cell line THP1". Cell. Immunol. 132 (1): 10–6. doi:10.1016/0008-8749(91)90002-S. PMID 1905983.
• Rosenstein Y, Burakoff SJ, Herrmann SH (1990). "HIV-gp120 can block CD4-class II MHC-mediated adhesion". J. Immunol. 144 (2): 526–31. PMID 1967269.
• Callahan KM, Fort MM, Obah EA, et al. (1990). "Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor". J. Immunol. 144 (9): 3341–6. PMID 1970352.
• Bowman MR, MacFerrin KD, Schreiber SL, Burakoff SJ (1991). "Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules". Proc. Natl. Acad. Sci. U.S.A. 87 (22): 9052–6. doi:10.1073/pnas.87.22.9052. PMC 55099. PMID 1978941.
• Koppelman B, Cresswell P (1990). "Rapid nonlysosomal degradation of assembled HLA class II glycoproteins incorporating a mutant DR alpha-chain". J. Immunol. 145 (8): 2730–6. PMID 2212658.
• Clayton LK, Sieh M, Pious DA, Reinherz EL (1989). "Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding". Nature. 339 (6225): 548–51. Bibcode:1989Natur.339..548C. doi:10.1038/339548a0. PMID 2543930. S2CID 4246781.
• Diamond DC, Sleckman BP, Gregory T, et al. (1988). "Inhibition of CD4+ T cell function by the HIV envelope protein, gp120". J. Immunol. 141 (11): 3715–7. PMID 2846691.
• Tjernlund U, Scheynius A, Johansson C, et al. (1989). "T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens". Scand. J. Immunol. 28 (6): 667–73. doi:10.1111/j.1365-3083.1988.tb01500.x. PMID 3266023. S2CID 25824282.
• Andrieu JM, Even P, Venet A (1986). "AIDS and related syndromes as a viral-induced autoimmune disease of the immune system: an anti-MHC II disorder. Therapeutic implications". AIDS Research. 2 (3): 163–74. doi:10.1089/aid.1.1986.2.163. PMID 3489470.
• Das HK, Lawrance SK, Weissman SM (1983). "Structure and nucleotide sequence of the heavy chain gene of HLA-DR". Proc. Natl. Acad. Sci. U.S.A. 80 (12): 3543–7. Bibcode:1983PNAS...80.3543D. doi:10.1073/pnas.80.12.3543. PMC 394085. PMID 6304715.
• Schamboeck A, Korman AJ, Kamb A, Strominger JL (1984). "Organization of the transcriptional unit of a human class II histocompatibility antigen: HLA-DR heavy chain". Nucleic Acids Res. 11 (24): 8663–75. doi:10.1093/nar/11.24.8663. PMC 326615. PMID 6324094.
• Das HK, Biro PA, Cohen SN, et al. (1983). "Use of synthetic oligonucleotide probes complementary to genes for human HLA-DR alpha and beta as extension primers for the isolation of 5'-specific genomic clones". Proc. Natl. Acad. Sci. U.S.A. 80 (6): 1531–5. Bibcode:1983PNAS...80.1531D. doi:10.1073/pnas.80.6.1531. PMC 393635. PMID 6403940.